ARISTEIA CAPITAL, L.L.C. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 61 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ARISTEIA CAPITAL, L.L.C. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$3,251,970
+1.8%
300,0000.0%0.09%
+22.5%
Q2 2023$3,195,000
-77.7%
300,000
-78.1%
0.07%
-78.9%
Q1 2023$14,306,057
+178.6%
1,370,312
+173.8%
0.34%
+226.2%
Q4 2022$5,134,114
+120.0%
500,401
+115.5%
0.10%
+151.2%
Q3 2022$2,334,000232,2560.04%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$6851.08%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,482,836$15,2440.42%
MMCAP International Inc. SPC 400,000$4,088,0000.42%
CANTOR FITZGERALD, L. P. 1,422,204$14,5570.31%
KIM, LLC 500,000$5,1400.28%
Spartan Fund Management Inc. 74,485$7630.28%
Saba Capital Management, L.P. 1,791,845$18,384,3300.25%
Atalaya Capital Management LP 125,000$1,285,0000.23%
Radcliffe Capital Management, L.P. 555,355$5,697,9420.18%
Exos TFP Holdings LLC 62,500$638,7500.18%
View complete list of BIOPLUS ACQUISITION CORP shareholders